scorecardresearch
Business Today
Subscribe
PMS Today US News India UPSTART Weather BT Shorts NRI Education Election
BT Golf BT Mindrush BT Best Banks
Clear all
Search

COMPANIES

No Data Found

NEWS

No Data Found
Sign in Subscribe
events
Special
  • BT tech today
  • BT 500 wealth creators summit
  • Economic Indicators
News
Markets
Stocks
Supriya Lifescience Ltd

Feedback
Supriya Lifescience Ltd

Supriya Lifescience Ltd (SUPRIYA) Share Price

  • Sector: Pharmaceuticals (Small Cap)
  • Volume: 157,203
Mar 13, 2025 15:59 IST-
  • NSE
  • BSE
  • Share
    • Whatsapp
    • Twitter
    • Facebook
₹597.45
₹-21.55 (-3.48%)
₹594.75 Low
Today’s Performance
₹639.5 High
₹305.5 Low
52 Week’s Performance
₹835.2 High

STOCK ANALYSIS

STOCK PERFORMANCE

  • 1 Day -3.48%
  • 1 Week -4.89%
  • 1 Month -13.46%
  • 3 Months -19.01%
  • 6 Months -3.86%
  • 1 Year 92.88%
  • 3 Years 10.04%
  • 5 Years 0.00%

PEER COMPARISON

STOCK SUMMARY

  • Face Value (₹) 2.00
  • Beta 1.57
  • 52-Week Low (₹) 305.50
  • 52-Week High (₹) 835.20
  • Price-to-Book (X)* 5.31
  • Dividend Yield (%) 0.13
  • Price-to-Earnings (P/E) (X)* 27.59
  • Earnings Per Share (₹) 21.68
  • Sector Price Earning (X)* 32.46
  • Market Cap (₹ Cr.)* 4,808.44
  • * Vaues as of last close price

COMPETITORS

BT TV

Navneet Munot: Short-Term Moves Are Unpredictable, But Long-Term Investors Will Gain 1:48 Navneet Munot: Short-Term Moves Are Unpredictable, But Long-Term Investors Will Gain
Jamie Dimon On Remote Work: Why WFH Doesn’t Work For JPMorgan 5:37 Jamie Dimon On Remote Work: Why WFH Doesn’t Work For JPMorgan
Investing In Adani Group: Expert Reveals The Most Promising Stock For Long-Term Growth 1:21 Investing In Adani Group: Expert Reveals The Most Promising Stock For Long-Term Growth
Top Expert Analyses The Potential Recessionary Impact Of US President Trump's Trade War 1:29 Top Expert Analyses The Potential Recessionary Impact Of US President Trump's Trade War
Inside Jagan Mohan's Rushikonda Palace: Luxury, Controversy & Unused Grandeur 5:24 Inside Jagan Mohan's Rushikonda Palace: Luxury, Controversy & Unused Grandeur
View more

FINANCIAL ANALYSIS

Income Statement (₹ Cr.)
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)
Income Statement (₹ Cr.)
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)

RATIO ANALYSIS

Return on Equity (%)
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)
Return on Equity (%)
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)

SHAREHOLDING PATTERN

Summary (as on 30 sep 2022)

DEALS

  • NSE
  • BSE

No Data For Block Deal.

*Single trade that involves transaction of a minimum quantity of 5 lakh shares or a minimum value of ₹ 10 crore.
Mar 27, 2023 Sell
DOVETAIL INDIA FUND CLASS 6 SHARES
  • Qty 547398
  • Average Price ₹177.08
Jan 24, 2022 PURCHASE
GRAVITON RESEARCH CAPITAL LLP
  • Qty 487816
  • Average Price ₹460.03
Jan 24, 2022 Sell
GRAVITON RESEARCH CAPITAL LLP
  • Qty 487816
  • Average Price ₹460.52
Jan 21, 2022 PURCHASE
GRAVITON RESEARCH CAPITAL LLP
  • Qty 542220
  • Average Price ₹526.90
Jan 21, 2022 Sell
GRAVITON RESEARCH CAPITAL LLP
  • Qty 542220
  • Average Price ₹526.43
Jan 18, 2022 PURCHASE
GRAVITON RESEARCH CAPITAL LLP
  • Qty 914497
  • Average Price ₹572.78
Jan 18, 2022 Sell
GRAVITON RESEARCH CAPITAL LLP
  • Qty 914497
  • Average Price ₹573.29
Dec 30, 2021 PURCHASE
GRAVITON RESEARCH CAPITAL LLP
  • Qty 984322
  • Average Price ₹499.96
Dec 30, 2021 PURCHASE
VAIBHAV STOCK AND DERIVATIVES BROKING PRIVATE LIMITED
  • Qty 711595
  • Average Price ₹503.76
Dec 30, 2021 Sell
VAIBHAV STOCK AND DERIVATIVES BROKING PRIVATE LIMITED
  • Qty 711595
  • Average Price ₹503.95
*Involves transaction of at least 0.5% of the listed shares of a company.

FAQ’S

What was Supriya Lifescience Ltd share price previously?
Supriya Lifescience Ltd share price was down by -3.48% from the previous closing price of ₹619.00.
Who are peers of Supriya Lifescience Ltd?
The peers of Supriya Lifescience Ltd are Sun Pharmaceuticals Industries Ltd, Divis Laboratories Ltd, Cipla Ltd, Torrent Pharmaceuticals Ltd, Dr Reddys Laboratories Ltd, Mankind Pharma Ltd, Lupin Ltd.
Who is/are the promoter/promoters of Supriya Lifescience Ltd?
The promotor/promotors of Supriya Lifescience Ltd are Satish Waman Wagh, Smita Satish Wagh, Soloni Satish Wagh, Shivani Satish Wagh, Balasahab Gulabrao Sawant, Dileep Kumar Jain, Dinesh N Modi, Neelam Yashpal Arora, Manoj Deo Dorlikar, Ganapati D Yadav, Sunil Subhash Bhagwat, Prachi Sathe.
What has been 52-week high of Supriya Lifescience Ltd stocks?
The highest price of Supriya Lifescience Ltd stock is ₹835.20 in the last 52-week.
What is the share price of Supriya Lifescience Ltd (SUPRIYA) today on NSE?
As on Mar 13, 2025, Supriya Lifescience Ltd (SUPRIYA)’s share price on NSE is Rs 597.45
What is the market cap of Supriya Lifescience Ltd (SUPRIYA?)
The current market capitalisation of Supriya Lifescience Ltd (SUPRIYA) is 4,808.44 crores
What is Supriya Lifescience Ltd Share symbol?
The symbol of Supriya Lifescience Ltd is SUPRIYA.
What is the PE ratio of Supriya Lifescience Ltd (SUPRIYA)?
The current PE ratio of Supriya Lifescience Ltd (SUPRIYA) is 27.59.
What is the PB ratio of Supriya Lifescience Ltd (SUPRIYA)?
The current PB ratio of Supriya Lifescience Ltd (SUPRIYA) is 5.31.
Today’s High & Low share prices of Supriya Lifescience Ltd (SUPRIYA) on NSE?
Today, the share price of Supriya Lifescience Ltd (SUPRIYA) on NSE touched a high of Rs 639.5 and a low of Rs 594.75
What price did Supriya Lifescience Ltd (SUPRIYA) shares open on the NSE today?
On NSE, the share price of Supriya Lifescience Ltd (SUPRIYA) opened at Rs 624.6
What is the 52-week high of Supriya Lifescience Ltd (SUPRIYA)?
The 52-week high price of Supriya Lifescience Ltd (SUPRIYA) is Rs 835.2
What is the 52-week low of Supriya Lifescience Ltd (SUPRIYA) ?
The 52-week low price of Supriya Lifescience Ltd (SUPRIYA) is Rs 305.5

ABOUT SUPRIYA LIFESCI.

Supriya Lifescience Ltd, incorporated in the year 2008, has its registered office in 207/208 Udyog Bhavan, Sonawala Road Goregaon (East), Mumbai, Maharashtra, 400063, 91-22-40332727. The main industry in which Supriya Lifescience Ltd operates is Pharmaceuticals - Indian - Bulk Drugs & Formln.

Auditor/Auditors for Supriya Lifescience Ltd is/are Kakaria & Associates LLP. In the main management, Satish Waman Wagh is chairman and Prachi Sathe is the company secretary for Supriya Lifescience Ltd.

  • SWW Satish Waman Wagh Chairman & Managing Director
  • SSW Smita Satish Wagh Whole-time Director
  • SSW Soloni Satish Wagh Whole-time Director
  • SSW Shivani Satish Wagh Whole-time Director
  • BGS Balasahab Gulabrao Sawant Whole-time Director
  • DKJ Dileep Kumar Jain Independent Director
  • DNM Dinesh N Modi Independent Director
  • NYA Neelam Yashpal Arora Independent Director
  • MDD Manoj Deo Dorlikar Whole-time Director
  • GDY Ganapati D Yadav Additional Director
  • SSB Sunil Subhash Bhagwat Additional Director
  • PS Prachi Sathe Company Sec. & Compli. Officer

Top Stories

Thank you! Your transaction has been completed successfully.
Sorry! Transaction failed. Please try again later.

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.

Advertisement